Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah J L Wong

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Treatment and Research|November 26, 2015
Targeted Therapy for MelanomaDeborah J L Wong, Antoni Ribas
Annals of Translational Medicine|January 9, 2015
Recent advances in the development of anti-HER2 antibodies and antibody-drug conjugatesDeborah J L Wong, Sara A Hurvitz
Oncology (Williston Park, N.Y.)|August 20, 2014
Cardiotoxicity of targeted agents in oncology: a medical oncology perspectiveDeborah J L Wong, Sara A Hurvitz
Plos One|August 18, 2016
Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network ModelScott B Hu, Deborah J L Wong, Aditi Correa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Effects of MAPK and PI3K pathways on PD-L1 expression in melanomaMohammad Atefi, Earl Avramis, Amanda Lassen, et al.
Molecular Cancer|February 4, 2015
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanomaMohammad Atefi, Bjoern Titz, Earl Avramis, et al.
Cancer Immunology Research|May 6, 2014
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and functionDeborah J L Wong, Amol Rao, Earl Avramis, et al.
Molecular Cancer|July 3, 2015
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Molecular Cancer|August 22, 2014
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Treatment and Research|November 26, 2015
Targeted Therapy for MelanomaDeborah J L Wong, Antoni Ribas
Annals of Translational Medicine|January 9, 2015
Recent advances in the development of anti-HER2 antibodies and antibody-drug conjugatesDeborah J L Wong, Sara A Hurvitz
Oncology (Williston Park, N.Y.)|August 20, 2014
Cardiotoxicity of targeted agents in oncology: a medical oncology perspectiveDeborah J L Wong, Sara A Hurvitz
Plos One|August 18, 2016
Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network ModelScott B Hu, Deborah J L Wong, Aditi Correa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Effects of MAPK and PI3K pathways on PD-L1 expression in melanomaMohammad Atefi, Earl Avramis, Amanda Lassen, et al.
Molecular Cancer|February 4, 2015
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanomaMohammad Atefi, Bjoern Titz, Earl Avramis, et al.
Cancer Immunology Research|May 6, 2014
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and functionDeborah J L Wong, Amol Rao, Earl Avramis, et al.
Molecular Cancer|July 3, 2015
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Molecular Cancer|August 22, 2014
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
Pageof 2